148 related articles for article (PubMed ID: 18080842)
21. A-methylacyl-CoA racemase (AMACR) and prostate-cancer risk: a meta-analysis of 4,385 participants.
Jiang N; Zhu S; Chen J; Niu Y; Zhou L
PLoS One; 2013; 8(10):e74386. PubMed ID: 24130666
[TBL] [Abstract][Full Text] [Related]
22. Alpha-methylacyl-CoA racemase deletion has mutually counteracting effects on T-cell responses, associated with unchanged course of EAE.
Tafferner N; Barthelmes J; Eberle M; Ulshöfer T; Henke M; deBruin N; Mayer CA; Foerch C; Geisslinger G; Parnham MJ; Schiffmann S
Eur J Immunol; 2016 Mar; 46(3):570-81. PubMed ID: 26648339
[TBL] [Abstract][Full Text] [Related]
23. alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer.
Rubin MA; Zhou M; Dhanasekaran SM; Varambally S; Barrette TR; Sanda MG; Pienta KJ; Ghosh D; Chinnaiyan AM
JAMA; 2002 Apr; 287(13):1662-70. PubMed ID: 11926890
[TBL] [Abstract][Full Text] [Related]
24. A mouse model for alpha-methylacyl-CoA racemase deficiency: adjustment of bile acid synthesis and intolerance to dietary methyl-branched lipids.
Savolainen K; Kotti TJ; Schmitz W; Savolainen TI; Sormunen RT; Ilves M; Vainio SJ; Conzelmann E; Hiltunen JK
Hum Mol Genet; 2004 May; 13(9):955-65. PubMed ID: 15016763
[TBL] [Abstract][Full Text] [Related]
25. Alpha-methylacyl-CoA racemase from Mycobacterium tuberculosis. Mutational and structural characterization of the active site and the fold.
Savolainen K; Bhaumik P; Schmitz W; Kotti TJ; Conzelmann E; Wierenga RK; Hiltunen JK
J Biol Chem; 2005 Apr; 280(13):12611-20. PubMed ID: 15632186
[TBL] [Abstract][Full Text] [Related]
26. A Novel Monoclonal Antibody Against Alpha-Methylacyl-CoA Racemase Applicable for Paraffin-Embedded Tissues and Diagnostics of Prostate Cancer.
Kovaleva OV; Samoilova DV; Shitova MS; Oleinikova NA; Danilova NV; Malkov PG; Gratchev A
Monoclon Antib Immunodiagn Immunother; 2017 Feb; 36(1):30-34. PubMed ID: 28234557
[TBL] [Abstract][Full Text] [Related]
27. Conversion of prostate cancer from hormone independency to dependency due to AMACR inhibition: involvement of increased AR expression and decreased IGF1 expression.
Takahara K; Azuma H; Sakamoto T; Kiyama S; Inamoto T; Ibuki N; Nishida T; Nomi H; Ubai T; Segawa N; Katsuoka Y
Anticancer Res; 2009 Jul; 29(7):2497-505. PubMed ID: 19596919
[TBL] [Abstract][Full Text] [Related]
28. Trifluoroibuprofen inhibits α-methylacyl coenzyme A racemase (AMACR/P504S), reduces cancer cell proliferation and inhibits in vivo tumor growth in aggressive prostate cancer models.
Festuccia C; Gravina GL; Mancini A; Muzi P; Cesare ED; Kirk R; Smith M; Hughes S; Gibson R; Lian LY; Ricevuto E; Carnell AJ
Anticancer Agents Med Chem; 2014; 14(7):1031-41. PubMed ID: 24712326
[TBL] [Abstract][Full Text] [Related]
29. Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.
Daugherty SE; Shugart YY; Platz EA; Fallin MD; Isaacs WB; Pfeiffer RM; Welch R; Huang WY; Reding D; Hayes RB
Prostate; 2007 Oct; 67(14):1487-97. PubMed ID: 17680641
[TBL] [Abstract][Full Text] [Related]
30. In mouse alpha -methylacyl-CoA racemase, the same gene product is simultaneously located in mitochondria and peroxisomes.
Kotti TJ; Savolainen K; Helander HM; Yagi A; Novikov DK; Kalkkinen N; Conzelmann E; Hiltunen JK; Schmitz W
J Biol Chem; 2000 Jul; 275(27):20887-95. PubMed ID: 10770938
[TBL] [Abstract][Full Text] [Related]
31. Alpha-methylacyl-CoA racemase: a multi-institutional study of a new prostate cancer marker.
Jiang Z; Wu CL; Woda BA; Iczkowski KA; Chu PG; Tretiakova MS; Young RH; Weiss LM; Blute RD; Brendler CB; Krausz T; Xu JC; Rock KL; Amin MB; Yang XJ
Histopathology; 2004 Sep; 45(3):218-25. PubMed ID: 15330799
[TBL] [Abstract][Full Text] [Related]
32. A variant of the alpha-methyl-acyl-CoA racemase gene created by a deletion in exon 5 and its expression in prostate cancer.
Mubiru JN; Valente AJ; Troyer DA
Prostate; 2005 Oct; 65(2):117-23. PubMed ID: 15880524
[TBL] [Abstract][Full Text] [Related]
33. α-Methylacyl-CoA racemase spliced variants and their expression in normal and malignant prostate tissues.
Ouyang B; Leung YK; Wang V; Chung E; Levin L; Bracken B; Cheng L; Ho SM
Urology; 2011 Jan; 77(1):249.e1-7. PubMed ID: 21195844
[TBL] [Abstract][Full Text] [Related]
34. Humoral immune response to alpha-methylacyl-CoA racemase and prostate cancer.
Sreekumar A; Laxman B; Rhodes DR; Bhagavathula S; Harwood J; Giacherio D; Ghosh D; Sanda MG; Rubin MA; Chinnaiyan AM
J Natl Cancer Inst; 2004 Jun; 96(11):834-43. PubMed ID: 15173267
[TBL] [Abstract][Full Text] [Related]
35. Prostate Cancer Diagnosis Using Urine Sediment Analysis-Based α-Methylacyl-CoA Racemase Score: A Single-Center Experience.
Ji J; Chen X; Xu Y; Cao Z; Xu H; Kong C; Wang F; Sun Y
Cancer Control; 2019; 26(1):1073274819887697. PubMed ID: 31793344
[TBL] [Abstract][Full Text] [Related]
36. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer.
Zhou M; Jiang Z; Epstein JI
Am J Surg Pathol; 2003 Jun; 27(6):772-8. PubMed ID: 12766580
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning and characterization of human homeobox gene Nkx3.1 promoter.
Jiang AL; Zhang JY; Young C; Hu XY; Wang YM; Liu ZF; Hao ML
Acta Biochim Biophys Sin (Shanghai); 2004 Jan; 36(1):64-7. PubMed ID: 14732878
[TBL] [Abstract][Full Text] [Related]
38. Utility of alpha-methylacyl coenzyme A racemase (p504s antibody) as a diagnostic immunohistochemical marker for cancer.
Nassar A; Amin MB; Sexton DG; Cohen C
Appl Immunohistochem Mol Morphol; 2005 Sep; 13(3):252-5. PubMed ID: 16082251
[TBL] [Abstract][Full Text] [Related]
39. The prostate-specific G-protein coupled receptors PSGR and PSGR2 are prostate cancer biomarkers that are complementary to alpha-methylacyl-CoA racemase.
Wang J; Weng J; Cai Y; Penland R; Liu M; Ittmann M
Prostate; 2006 Jun; 66(8):847-57. PubMed ID: 16491480
[TBL] [Abstract][Full Text] [Related]
40. Alpha-methylacyl-CoA racemase (AMACR) protein is upregulated in early proliferative lesions of the breast irrespective of apocrine differentiation.
Gatalica Z; Stafford P; Vranic S
Hum Pathol; 2022 Nov; 129():40-46. PubMed ID: 35998819
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]